Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Survival and recurrence of endometrial adenocarcinoma].
Sinistrero G, Sismondi P, Zola P, Gribaudo S, Danese S, Bellora MG. Sinistrero G, et al. Among authors: danese s. Radiol Med. 1994 May;87(5):677-82. Radiol Med. 1994. PMID: 8008900 Italian.
Variation in gynecological oncology follow-up practice: attributable to cancer centers or to patient characteristics? A Piedmont Regional Oncology Network Study.
Fuso L, Evangelista A, Pagano E, Piovano E, Perotto S, Mazzola S, Bertoldo E, La Porta MR, Rosmino C, Furbatto G, Abate S, Di Costanzo G, Trossarelli G, Baù MG, Carnino F, Gambaro G, Piantanida P, Alabiso O, Galletto L, Zavallone L, Rossi A, Barbero M, Tessa M, Katsaros D, Danese S, Brignolo P, Gorzegno G, Grillo R, Apolone G, Ciccone G. Fuso L, et al. Among authors: danese s. Tumori. 2011 Sep-Oct;97(5):551-8. doi: 10.1177/030089161109700502. Tumori. 2011. PMID: 22158482
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡.
Conte P, Frassoldati A, Bisagni G, Brandes AA, Donadio M, Garrone O, Piacentini F, Cavanna L, Giotta F, Aieta M, Gebbia V, Molino A, Musolino A, Ferro A, Maltoni R, Danese S, Zamagni C, Rimanti A, Cagossi K, Russo A, Pronzato P, Giovanardi F, Moretti G, Lombardo L, Schirone A, Beano A, Amaducci L, Bajardi EA, Vicini R, Balduzzi S, D'Amico R, Guarneri V. Conte P, et al. Among authors: danese s. Ann Oncol. 2018 Dec 1;29(12):2328-2333. doi: 10.1093/annonc/mdy414. Ann Oncol. 2018. PMID: 30219886 Free article. Clinical Trial.
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial.
Del Mastro L, Levaggi A, Michelotti A, Cavazzini G, Adami F, Scotto T, Piras M, Danese S, Garrone O, Durando A, Accortanzo V, Bighin C, Miglietta L, Pastorino S, Pronzato P, Castiglione F, Landucci E, Conte P, Bruzzi P. Del Mastro L, et al. Among authors: danese s. Breast Cancer Res Treat. 2016 Jan;155(1):117-26. doi: 10.1007/s10549-015-3655-1. Epub 2015 Dec 10. Breast Cancer Res Treat. 2016. PMID: 26661403 Clinical Trial.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
Dieci MV, Bisagni G, Brandes AA, Frassoldati A, Cavanna L, Giotta F, Aieta M, Gebbia V, Musolino A, Garrone O, Donadio M, Rimanti A, Beano A, Zamagni C, Soto Parra H, Piacentini F, Danese S, Ferro A, Cagossi K, Sarti S, Gambaro AR, Romito S, Bazan V, Amaducci L, Moretti G, Foschini MP, Balduzzi S, Vicini R, D'Amico R, Griguolo G, Guarneri V, Conte PF. Dieci MV, et al. Among authors: danese s. BMC Med. 2019 Nov 21;17(1):207. doi: 10.1186/s12916-019-1445-z. BMC Med. 2019. PMID: 31747948 Free PMC article. Clinical Trial.
1,120 results